SCHEMBL5492501

SCHEMBL5492501

CCC(CCO)SCC(N)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 3/20 0.40
SLC1A2 P43004 3/20 0.40
SLC1A1 P43005 3/20 0.40
GCLC P48506 2/20 0.40
GRIK1 P39086 2/20 0.39
GRIK2 Q13002 2/20 0.39
GSR P00390 2/20 0.39
GRM8 O00222 1/20 0.39
GRM6 O15303 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
CYP1A2 P05177 1/20 0.39
GRM5 P41594 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39
GRIA4 P48058 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIK3 Q13003 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30368430 0.88 GRIK1 (0.44) SLC1A3SLC1A2SLC1A1GRIK1GRIK2
SCHEMBL5484085 0.88 GRIK1 (0.44) SLC1A3SLC1A2SLC1A1GRIK1GRIK2
SCHEMBL15826574 0.81 MME (0.40)
SCHEMBL15846835 0.81 MME (0.40)
Homoserine SCHEMBL27743664 0.78 GSR (0.54) SLC1A3SLC1A2SLC1A1GRIK1GRIK2
Homoserine SCHEMBL28042341 0.78 GSR (0.54) SLC1A3SLC1A2SLC1A1GRIK1GRIK2
Homoserine SCHEMBL20299187 0.76 SLC1A3 (0.52) SLC1A3SLC1A2SLC1A1GCLCGRIK1
SCHEMBL9046092 0.75 SLC1A3 (0.47) SLC1A3SLC1A2SLC1A1GRIK1GRIK2
Homoserine SCHEMBL6446994 0.73 GSR (0.59) SLC1A3SLC1A2SLC1A1GRIK1GRIK2
Homoserine SCHEMBL29649 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858378-B2 Method for the determination of body odor KAO CORPORATION (JP) 2010-12-28 US disclosed
US-7858378-B2 Method for the determination of body odor KAO CORPORATION (JP) 2010-12-28 US disclosed
US-20100035355-A1 METHOD FOR THE DETERMINATION OF BODY ODOR KAO CORPORATION (JP) 2010-02-11 US disclosed
US-20100035355-A1 METHOD FOR THE DETERMINATION OF BODY ODOR KAO CORPORATION (JP) 2010-02-11 US disclosed
US-7608459-B2 Method for the determination of body odor KAO CORPORATION (JP) 2009-10-27 US disclosed
US-7608459-B2 Method for the determination of body odor KAO CORPORATION (JP) 2009-10-27 US disclosed
US-20080014649-A1 Method for the Determination of Body Odor KAO CORPORATION (JP) 2008-01-17 US disclosed
US-20080014649-A1 Method for the Determination of Body Odor KAO CORPORATION (JP) 2008-01-17 US disclosed
EP-1757933-A1 METHOD FOR THE DETERMINATION OF BODY ODOR Kao Corporation (JP) 2007-02-28 EP disclosed
EP-1757933-A1 METHOD FOR THE DETERMINATION OF BODY ODOR Kao Corporation (JP) 2007-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035355-A1 METHOD FOR THE DETERMINATION OF BODY ODOR OR10J3, OR51E2, DRD4 SLC1A3 2680/4885SLC1A2 2297/4885SLC1A1 2159/4885
US-20080014649-A1 Method for the Determination of Body Odor OR10J3, OR51E2, DRD4 SLC1A3 2680/4885SLC1A2 2297/4885SLC1A1 2159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.